John Couling Sells 7,667 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the company’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $61.05, for a total transaction of $468,070.35. Following the transaction, the senior vice president owned 118,727 shares in the company, valued at approximately $7,248,283.35. The trade was a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Trading Down 0.2%

Shares of NYSE:DLB opened at $61.81 on Friday. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $73.78. The stock has a market cap of $5.79 billion, a PE ratio of 26.30 and a beta of 0.80. The stock’s fifty day simple moving average is $56.58 and its two-hundred day simple moving average is $58.33.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings results on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business had revenue of $305.00 million for the quarter, compared to analyst estimates of $311.96 million. During the same period last year, the company posted $0.78 earnings per share. Dolby Laboratories’s quarterly revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. On average, sell-side analysts forecast that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.

Dolby Laboratories announced that its Board of Directors has authorized a stock repurchase program on Thursday, July 30th that permits the company to repurchase $350.00 million in shares. This repurchase authorization permits the electronics maker to reacquire up to 7% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s board believes its stock is undervalued.

Dolby Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were paid a dividend of $0.36 per share. The ex-dividend date was Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio is presently 61.28%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Boothbay Fund Management LLC increased its holdings in shares of Dolby Laboratories by 4.1% in the second quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after purchasing an additional 157 shares during the period. Covestor Ltd grew its position in Dolby Laboratories by 6.0% during the fourth quarter. Covestor Ltd now owns 3,088 shares of the electronics maker’s stock worth $198,000 after buying an additional 175 shares in the last quarter. Fifth Third Bancorp grew its position in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock worth $48,000 after buying an additional 192 shares in the last quarter. State of Michigan Retirement System increased its stake in Dolby Laboratories by 1.4% in the 1st quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after acquiring an additional 200 shares during the last quarter. Finally, Raymond James Financial Inc. increased its stake in Dolby Laboratories by 1.0% in the 2nd quarter. Raymond James Financial Inc. now owns 24,344 shares of the electronics maker’s stock worth $1,808,000 after acquiring an additional 235 shares during the last quarter. 58.56% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

DLB has been the topic of several recent research reports. Weiss Ratings downgraded shares of Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, August 28th. Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Dolby Laboratories currently has an average rating of “Hold” and an average target price of $87.50.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.